发布求助
文献互助 智能选刊 最新文献

Endocrinologia Diabetes Y Nutricion最新文献

筛选
英文 中文
Hyperglycemia-related risk factors in enteral nutrition in non-critically ill patients
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2025-03-01 DOI: 10.1016/j.endien.2025.101534
Esther Delgado-García , Juan José López-Gómez , Rebeca Jiménez-Sahagún , Emilia Gómez-Hoyos , Ana Ortolá-Buigues , Paloma Pérez-López , Beatriz Torres-Torres , Daniel A. De Luis-Román
{"title":"Hyperglycemia-related risk factors in enteral nutrition in non-critically ill patients","authors":"Esther Delgado-García ,&nbsp;Juan José López-Gómez ,&nbsp;Rebeca Jiménez-Sahagún ,&nbsp;Emilia Gómez-Hoyos ,&nbsp;Ana Ortolá-Buigues ,&nbsp;Paloma Pérez-López ,&nbsp;Beatriz Torres-Torres ,&nbsp;Daniel A. De Luis-Román","doi":"10.1016/j.endien.2025.101534","DOIUrl":"10.1016/j.endien.2025.101534","url":null,"abstract":"<div><h3>Introduction</h3><div>Carbohydrate metabolism can change in hospitalized patients due to stress, or the use of enteral nutrition (EN). The aim of this study was to determine the risk factors triggering these changes.</div></div><div><h3>Material and Methods</h3><div>We conducted a retrospective observational study in non-diabetic patients with low levels of stress on EN. Five groups were categorized based on changes to the metabolism of hydrocarbons produced before or after EN: plasma glycemia prior to EN &gt;126<!--> <!-->mg/dL (stress hyperglycemia – SH) (35.1%); plasma glycaemia prior to EN &lt;126<!--> <!-->mg/dL (non-HE) (64.89%). Hyperglycemia with EN (HyperEN): at least, two capillary blood glucose readings &gt;140<!--> <!-->mg/dL or 1 &gt;180<!--> <!-->mg/dL during EN (71%); non-HyperEN: capillary blood glucose readings with EN &lt;140<!--> <!-->mg/dL (29%).</div></div><div><h3>Results</h3><div>A total of 131 patients were included (45.8% men) with a median age of 81 (71–87) years. A total of 52 patients exceeded 180<!--> <!-->mg/dL at one measurement, and 24 patients required insulin detemir with a median of 16 (12–27) IU per day. Risk factors for HyperEN were identified as patient age (OR, 1.186; 95% CI, 1.051–1.341; <em>p</em> <!-->&lt;<!--> <!-->0.01) and duration of nutritional treatment (OR, 1.320; 95% CI, 1.086–1.605; <em>p</em> <!-->&lt;<!--> <!-->0.01).</div></div><div><h3>Conclusions</h3><div>Our study shows a high prevalence of carbohydrate metabolism disorders in hospitalized patients on total EN, with age and duration of nutritional treatment being the main risk factors.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 3","pages":"Article 101534"},"PeriodicalIF":1.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143609170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short bowel syndrome and d-lactic acidosis: A case report with supplemental home parenteral nutrition and teduglutide
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2025-03-01 DOI: 10.1016/j.endien.2025.101535
Elena Carrillo-López, Maria Sara Tapia-Sanchiz, Sara Jiménez-Blanco, Begoña Molina-Baena
{"title":"Short bowel syndrome and d-lactic acidosis: A case report with supplemental home parenteral nutrition and teduglutide","authors":"Elena Carrillo-López,&nbsp;Maria Sara Tapia-Sanchiz,&nbsp;Sara Jiménez-Blanco,&nbsp;Begoña Molina-Baena","doi":"10.1016/j.endien.2025.101535","DOIUrl":"10.1016/j.endien.2025.101535","url":null,"abstract":"<div><div><span>d</span>-Lactic acidosis is an uncommon cause of acidosis that occurs in patients with short bowel syndrome (SBS). Reduced intestinal absorption surface leads to carbohydrate malabsorption, fermented by abnormal colonic bacterial flora, resulting in elevated <span>d</span>-lactate levels. It should be suspected in SBS patients who exhibit typical neurological symptoms without other apparent causes, along with metabolic acidosis with normal <span>l</span>-lactate levels. Treatment involves correcting acidosis and managing bacterial overgrowth with non-absorbable antibiotics.</div><div>This report presents a case of a patient on teduglutide for SBS who experienced an episode of <span>d</span>-lactic acidosis. To date, there are no documented cases in the literature of similar episodes in adult patients undergoing therapy with GLP2 analogs.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 3","pages":"Article 101535"},"PeriodicalIF":1.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143609171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New drugs in pituitary diseases
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2025-03-01 DOI: 10.1016/j.endien.2025.501546
Fernando Cordido , Pedro Iglesias
{"title":"New drugs in pituitary diseases","authors":"Fernando Cordido ,&nbsp;Pedro Iglesias","doi":"10.1016/j.endien.2025.501546","DOIUrl":"10.1016/j.endien.2025.501546","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 3","pages":"Article 501546"},"PeriodicalIF":1.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143609169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommendations of the Spanish Society of Endocrinology and Nutrition (SEEN) on “what not to do” in clinical practice
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2025-03-01 DOI: 10.1016/j.endien.2025.101531
Juan José Díez , Emma Anda , Irene Bretón , Cintia González-Blanco , María Miguélez , Ana Zugasti , Alberto Fernández , on behalf of the Sociedad Española de Endocrinología y Nutrición
{"title":"Recommendations of the Spanish Society of Endocrinology and Nutrition (SEEN) on “what not to do” in clinical practice","authors":"Juan José Díez ,&nbsp;Emma Anda ,&nbsp;Irene Bretón ,&nbsp;Cintia González-Blanco ,&nbsp;María Miguélez ,&nbsp;Ana Zugasti ,&nbsp;Alberto Fernández ,&nbsp;on behalf of the Sociedad Española de Endocrinología y Nutrición","doi":"10.1016/j.endien.2025.101531","DOIUrl":"10.1016/j.endien.2025.101531","url":null,"abstract":"<div><div>Quality healthcare should be grounded on clinical practice with the highest benefit-risk ratio and cost-effectiveness according to the available scientific evidence. The overuse of unproven diagnostic or therapeutic procedures is common in our setting and leads to increased healthcare spending and even iatrogenic harm. Previous cost-effectiveness initiatives have proposed identifying diagnostic and therapeutic measures that are better 'not done' in certain clinical contexts under the lens of the available scientific evidence. In this regard, the Spanish Society of Endocrinology and Nutrition (SEEN) has compiled a series of 'not-to-do' recommendations from its various working groups. These recommendations cover common clinical situations classified into the following thematic areas: diabetes, nutrition, pituitary gland, neuroendocrine tumors, thyroid, and hormone replacement therapy in postmenopausal women.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 3","pages":"Article 101531"},"PeriodicalIF":1.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143558029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of cell height in the tall cell subtype of papillary thyroid carcinoma. Is it a key factor in the prognosis?
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2025-03-01 DOI: 10.1016/j.endien.2025.101530
Ricard Onieva Carbajo , Joan Carles Ferreres Piñas , Flavia Alberto , Ismael Capel Flores , Martina Pérez , Maria Rosa Bella Cueto
{"title":"Analysis of cell height in the tall cell subtype of papillary thyroid carcinoma. Is it a key factor in the prognosis?","authors":"Ricard Onieva Carbajo ,&nbsp;Joan Carles Ferreres Piñas ,&nbsp;Flavia Alberto ,&nbsp;Ismael Capel Flores ,&nbsp;Martina Pérez ,&nbsp;Maria Rosa Bella Cueto","doi":"10.1016/j.endien.2025.101530","DOIUrl":"10.1016/j.endien.2025.101530","url":null,"abstract":"<div><h3>Introduction</h3><div>The tall cell subtype of papillary thyroid carcinoma (PTC) is considered to have poor prognosis, but its diagnostic criteria have been modified on several occasions. The aim of our study was to find the best diagnostic criteria to relate the tall cell subtype with aggressiveness and poor prognosis.</div></div><div><h3>Material and methods</h3><div>In 171 cases of classic subtype and tall cell subtype of PTC, the percentage of cells between two and three times taller than wide (C2−3) and cells more than three times taller than wide (Cx3) was determined by two observers, after obtaining reference images. Groups were made based on the percentage of cells of each component (&lt;2%, between 2 and 10%, between 11 and 30%, between 31 and 50% and &gt;50%) and were correlated with clinical and histopathological data. Interobserver agreement was also assessed.</div></div><div><h3>Results</h3><div>According to the current WHO classification criteria, only 8 cases (5%) of tall cell subtype were identified. The comparison of the risk of recurrence at 5 years based on the percentage and type of cells showed that it increased significantly from &gt;10% of the Cx3 cell component, while there were no significant differences in recurrence rate with any C2−3 cell percentages. Very good interobserver agreement was obtained (Kappa index: 0.83).</div></div><div><h3>Conclusions</h3><div>We consider relevant reporting the presence of Cx3 cells from 10% in PTC as it is associated with a significant increase in the recurrence rate at 5 years. Interobserver agreement is very good if reference images are available.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 3","pages":"Article 101530"},"PeriodicalIF":1.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solitary fibrous tumor in the thyroid gland as an incidental finding
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2025-03-01 DOI: 10.1016/j.endien.2025.101524
Luis Francisco de Miguel Rodríguez , Julieta Romina Arbat , Katherine García Malpartida , Pablo Fernández Collazo , Carlos Morillas Ariño
{"title":"Solitary fibrous tumor in the thyroid gland as an incidental finding","authors":"Luis Francisco de Miguel Rodríguez ,&nbsp;Julieta Romina Arbat ,&nbsp;Katherine García Malpartida ,&nbsp;Pablo Fernández Collazo ,&nbsp;Carlos Morillas Ariño","doi":"10.1016/j.endien.2025.101524","DOIUrl":"10.1016/j.endien.2025.101524","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 3","pages":"Article 101524"},"PeriodicalIF":1.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addendum to “The importance of MLPA technique in the diagnosis of multiple endocrine neoplasia type”, Endocrinología, Diabetes y Nutrición 71 (2024) 221-225
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2025-03-01 DOI: 10.1016/j.endien.2025.101540
Antonio Bustos-Merlo, Carlos Javier García Calvente, Antonio Rosales-Castillo
{"title":"Addendum to “The importance of MLPA technique in the diagnosis of multiple endocrine neoplasia type”, Endocrinología, Diabetes y Nutrición 71 (2024) 221-225","authors":"Antonio Bustos-Merlo,&nbsp;Carlos Javier García Calvente,&nbsp;Antonio Rosales-Castillo","doi":"10.1016/j.endien.2025.101540","DOIUrl":"10.1016/j.endien.2025.101540","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 3","pages":"Article 101540"},"PeriodicalIF":1.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143609167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical development of hypopituitarism due to septic embolism: A case report
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2025-03-01 DOI: 10.1016/j.endien.2025.101529
Jordi Tortosa-Carreres , Lorena Hernández-Rienda , Susana Tenés-Rodrigo , Amparo Alba-Redondo , María Luisa Martínez-Triguero
{"title":"Atypical development of hypopituitarism due to septic embolism: A case report","authors":"Jordi Tortosa-Carreres ,&nbsp;Lorena Hernández-Rienda ,&nbsp;Susana Tenés-Rodrigo ,&nbsp;Amparo Alba-Redondo ,&nbsp;María Luisa Martínez-Triguero","doi":"10.1016/j.endien.2025.101529","DOIUrl":"10.1016/j.endien.2025.101529","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 3","pages":"Article 101529"},"PeriodicalIF":1.8,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143609168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controversies on the effects of GLP-1 receptor agonist treatment on gastric emptying
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2025-02-01 DOI: 10.1016/j.endien.2025.101538
Miguel A. Rubio-Herrera , Irene Bretón Lesmes
{"title":"Controversies on the effects of GLP-1 receptor agonist treatment on gastric emptying","authors":"Miguel A. Rubio-Herrera ,&nbsp;Irene Bretón Lesmes","doi":"10.1016/j.endien.2025.101538","DOIUrl":"10.1016/j.endien.2025.101538","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 2","pages":"Article 101538"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143371143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2025-02-01 DOI: 10.1016/j.endien.2025.101523
Juan Pedro-Botet , Francisco Arrieta , Manuel Botana , José A. Gimeno-Orna , José I. Martínez-Montoro , Emilio Ortega-Martínez de Victoria , Josep Ribalta , Víctor Sánchez-Margalet , Antonio Pérez-Pérez , on behalf of the Grupo de Trabajo de Enfermedad Cardiovascular de la Sociedad Española de Diabetes
{"title":"Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society","authors":"Juan Pedro-Botet ,&nbsp;Francisco Arrieta ,&nbsp;Manuel Botana ,&nbsp;José A. Gimeno-Orna ,&nbsp;José I. Martínez-Montoro ,&nbsp;Emilio Ortega-Martínez de Victoria ,&nbsp;Josep Ribalta ,&nbsp;Víctor Sánchez-Margalet ,&nbsp;Antonio Pérez-Pérez ,&nbsp;on behalf of the Grupo de Trabajo de Enfermedad Cardiovascular de la Sociedad Española de Diabetes","doi":"10.1016/j.endien.2025.101523","DOIUrl":"10.1016/j.endien.2025.101523","url":null,"abstract":"<div><div>Patients with type 2 diabetes mellitus (T2DM) managed in both hospital and out-ofhospital settings usually have a high/very high cardiovascular risk, with a high burden of cardiovascular disease. All this justifies that the reduction of low-density lipoprotein cholesterol is the main therapeutic goal in T2DM. However, residual cardiovascular risk is very prevalent in T2DM, and is usually associated with atherogenic dyslipidemia and hyperlipoproteinemia(a); therefore, it is also necessary to reverse these lipoprotein abnormalities to achieve effective cardiovascular prevention. Given the considerable armamentarium of lipid-lowering drugs currently available, the Cardiovascular Disease Working Group of the Spanish Diabetes Society has considered it appropriate to carry out a narrative review and update of the effectiveness of these lipid-lowering drugs in the population with T2DM taking into account their effect on the lipoprotein profile and their potential impact on glycemic control.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 2","pages":"Article 101523"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信